The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 8,706,999 | 15,090,119 | SH | SOLE | 1,590,119 | 0 | 0 | |||
| AILERON THERAPEUTICS INC | COM NEW | 00887A204 | 1,968,204 | 830,466 | SH | SOLE | 830,466 | 0 | 0 | |||
| AMERICAN WELL CORP | CL A | 03044L105 | 29,646,279 | 10,475,717 | SH | SOLE | 10,475,717 | 0 | 0 | |||
| ANNEXON INC | COM | 03589W102 | 22,794,354 | 4,408,966 | SH | SOLE | 4,408,966 | 0 | 0 | |||
| AADI BIOSCIENCE INC | COM | 00032Q104 | 20,923,549 | 1,630,830 | SH | SOLE | 1,630,830 | 0 | 0 | |||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 2,895,750 | 2,227,500 | SH | SOLE | 2,227,500 | 0 | 0 | |||